BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2020
View Archived Issues
Profiling of JAK inhibitors AZD-4604 and AZD-0449 in translational rodent model of asthma
Read More
Oxygen grows tumors but shrinks metastasis chances
Read More
GlyT1 inhibitor BI-425809 to improve cognition impairment in schizophrenia
Read More
GTEx explores variation in genome bureaucracy
Read More
Killing persisters with less toxicity
Read More
miR-26a as biomarker of pulmonary exacerbation in cystic fibrosis
Read More
OD-66 restores hemoglobin levels in model of cancer-induced anemia
Read More
InflaRx initiates phase III of phase II/III study with IFX-1 in severe COVID-19-induced pneumonia
Read More
Lmito Therapeutics discloses NQO1 activators
Read More
Newave Pharmaceutical divulges BTK inhibitors
Read More
Cerepeut describes new quinazolinone compounds
Read More
Praxis Biotech presents new ISR pathway inhibitors
Read More
Novel IRE1 inhibitors identified by Genentech
Read More
Intranasal SARS-CoV-2 vaccine ChAd-SARS-CoV-2-S shows promise in vivo
Read More
Phase IIb topline results for Diamyd in type 1 diabetes
Read More
89bio reports phase Ib/IIa topline data on BIO89-100 in NASH
Read More
Celltrion reports interim phase I data of COVID-19 treatment candidate CT-P59 in healthy subjects
Read More
Immunity Pharma reports interim data from phase I/IIa study of IPL-344 in ALS
Read More
Cassava reports final phase IIb study results with sumifilam in Alzheimer's disease
Read More
CAEL-101 enters phase III program for AL amyloidosis
Read More
Gannex files IND for FXR agonist ASC-42 to treat NASH
Read More
FDA clears Vaxart's IND for phase I study of oral COVID-19 vaccine candidate
Read More
New phase II study evaluates patritumab deruxtecan for advanced/metastatic colorectal cancer
Read More
LB reports first-in-human data with amisulpride derivative LB-102
Read More
Clinuvel begins DNA repair program with Scenesse
Read More
ACTT-2 study of baricitinib plus remdesivir in COVID-19 meets primary endpoint
Read More
Cyxone plans to study rabeximod in phase II trial for COVID-19
Read More